Source:http://linkedlifedata.com/resource/pubmed/id/17397920
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2007-11-20
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0145-2126
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
32
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
191-2
|
| pubmed:meshHeading |
pubmed-meshheading:17397920-Adult,
pubmed-meshheading:17397920-Agammaglobulinemia,
pubmed-meshheading:17397920-Humans,
pubmed-meshheading:17397920-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:17397920-Male,
pubmed-meshheading:17397920-Piperazines,
pubmed-meshheading:17397920-Pyrimidines
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia.
|
| pubmed:publicationType |
Letter,
Case Reports
|